KDM6B and neurodegenerative disease: The activation of NF-κB-JMJD3 signaling were increased during inflammation in microglia cells and might promote the progress of neurodegenerative diseases including amyotrophic lateral sclerosis, Parkinson’s disease and Alzheimer’s disease, and resulted in damage to surrounding neural cells (Lee et al. 2014a, b).